


Healthcare News Roundup: FDA
HSMN NewsFeed - 29 Jul 2016
Micro Interventional Devices, Inc. Receives FDA Market Clearance for Permaseal(TM)
Micro Interventional Devices, Inc. Receives FDA Market Clearance for Permaseal(TM)
HSMN NewsFeed - 28 Jul 2016
Caladrius Biosciences Receives FDA Fast Track Designation for CLBS03 to Treat Recent Onset Type 1 Diabetes
Caladrius Biosciences Receives FDA Fast Track Designation for CLBS03 to Treat Recent Onset Type 1 Diabetes
HSMN NewsFeed - 22 Jul 2016
Amgen and UCB Submit Biologics License Application for Romosozumab to the FDA
Amgen and UCB Submit Biologics License Application for Romosozumab to the FDA
HSMN NewsFeed - 21 Jul 2016
Vasorum Ltd. Receives FDA Approval for Celt ACD(R) Vascular Closure Device
Vasorum Ltd. Receives FDA Approval for Celt ACD(R) Vascular Closure Device
HSMN NewsFeed - 20 Jul 2016
Viracor-IBT Laboratories, Inc.'s Zika Virus RT-PCR Test Receives Emergency Use Authorization From the FDA
Viracor-IBT Laboratories, Inc.'s Zika Virus RT-PCR Test Receives Emergency Use Authorization From the FDA
HSMN NewsFeed - 13 Jul 2016
SinuSys(TM) Corp. Receives FDA Clearance for the Vent-Os(R) Sinus Dilation Family of Devices
SinuSys(TM) Corp. Receives FDA Clearance for the Vent-Os(R) Sinus Dilation Family of Devices
HSMN NewsFeed - 12 Jul 2016
Alere to Initiate Voluntary Withdrawal of the Alere INRatio(R) and INRatio(R)2 PT/INR Monitoring System
Alere to Initiate Voluntary Withdrawal of the Alere INRatio(R) and INRatio(R)2 PT/INR Monitoring System
HSMN NewsFeed - 8 Jul 2016
Teligent, Inc. Receives Two FDA Approvals for Topical Prescription Portfolio
Teligent, Inc. Receives Two FDA Approvals for Topical Prescription Portfolio
HSMN NewsFeed - 6 Jul 2016
FDA Grants Merrimack Fast Track Designation for Seribantumab (MM-121) in Non-small Cell Lung Cancer
FDA Grants Merrimack Fast Track Designation for Seribantumab (MM-121) in Non-small Cell Lung Cancer
HSMN NewsFeed - 6 Jul 2016
US FDA pathway opens to SCENESSE(R) following Fast Track designation for treatment of EPP
US FDA pathway opens to SCENESSE(R) following Fast Track designation for treatment of EPP
HSMN NewsFeed - 29 Jun 2016
Biostage Files for FDA Orphan Drug Designation for Cellspan(TM) Esophageal Implant
Biostage Files for FDA Orphan Drug Designation for Cellspan(TM) Esophageal Implant
HSMN NewsFeed - 28 Jun 2016
FDA Grants Priority Review for Genentech’s OCREVUS(TM) (ocrelizumab) Biologics License Application
FDA Grants Priority Review for Genentech’s OCREVUS(TM) (ocrelizumab) Biologics License Application
HSMN NewsFeed - 21 Jun 2016
Perrigo Announces FDA Clearance And Launch Of Non-GMO* Infant Formulas For The U.S. Store Brand Market
Perrigo Announces FDA Clearance And Launch Of Non-GMO* Infant Formulas For The U.S. Store Brand Market
